Customizable Sustained Release from Oral Delivery Systems

The panel will be held at the MBC Office, One Cambridge Center, 9th Floor, Cambridge, MA. Get Directions.

The next talk in our series on methods of drug delivery will focus on oral delivery. New developments in this area allow for interesting customizable release profiles. The talk will provide more insight into the possibilities by showing how one such technology has been applied to a range of products.

In the area of oral drug delivery Geomatrix is a delivery technology that uses a 3 layered tablet. By controlling the swelling and gelling of this 3 layered tablet, the location, time and/or release profile of a drug can be controlled. This technology is well established as evident from the 10 new/reformulated products that have been approved in the US and/or Europe. The focus of the talk will be to provide a better understanding of the capabilities of Geomatrix and how it has been applied to various reformulation challenges.

Speaker

Christopher de Souza, SkyePharma

Christopher de Souza recently joined SkyePharma as their VP of Business Development. Prior to his new assignment, Christopher was Director of Strategic Alliances with Novartis where he used his strong scientific and business background to help support the research organization with innovative in-licensing technology, target and compound related deals. He is also actively associated with several community initiatives to foster economic development in the area and is a co-chair of the MBC's Business Development Committee.

Next meeting

Thursday May 29, 2008 12:00 -2 pm

If you have ideas you would like to suggest or topics in drug delivery of biologics and speakers for upcoming meetings and future presentations, please feel free to contact either Lori Gold at the MBC at lori.gold@massbio.org or Michiel Lodder at lodder@octoplus-inc.com.

We hope to see many of you there.